OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Neurology is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	76
Management of neuropsychiatric symptoms in dementia	68
Update on management of cerebral venous thrombosis	62
Assessing treatment response in multiple sclerosis	52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	50
The recent surge of functional movement disorders: social distress or greater awareness?	49
Editorial introductions	48
From basic mechanisms to therapeutic perspectives in cluster headache	47
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	45
Hereditary motor neuropathies	40
Historical development and contemporary use of neuromodulation in human spinal cord injury	40
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	39
Gene therapies for CMT neuropathies: from the bench to the clinic	38
Microglia in multiple sclerosis – pathogenesis and imaging	37
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population	35
Neurology education in the era of artificial intelligence	35
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond	31
Central nervous system adverse events of immune checkpoint inhibitors	30
Neurosyphilis in 2025: Erratum	30
The role of the gut microbiome in Alzheimer's disease pathophysiology	29
Editorial introductions	28
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	28
Updates in neuro-otology	28
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	26
Editorial: Epilepsy advances in 2023	26

New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	26
Multiple sclerosis in China: the current state of diagnosis and management	26